IL107557A - Lymphotropic agents and vectors - Google Patents

Lymphotropic agents and vectors

Info

Publication number
IL107557A
IL107557A IL10755793A IL10755793A IL107557A IL 107557 A IL107557 A IL 107557A IL 10755793 A IL10755793 A IL 10755793A IL 10755793 A IL10755793 A IL 10755793A IL 107557 A IL107557 A IL 107557A
Authority
IL
Israel
Prior art keywords
lymphotropic
vectors
agents
lymphotropic agents
Prior art date
Application number
IL10755793A
Other versions
IL107557A0 (en
Inventor
Niza Frenkel
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Priority to IL10755793A priority Critical patent/IL107557A/en
Publication of IL107557A0 publication Critical patent/IL107557A0/en
Priority to AU10885/95A priority patent/AU1088595A/en
Priority to US08/646,242 priority patent/US6503752B1/en
Priority to PCT/US1994/012715 priority patent/WO1995013081A1/en
Priority to US10/061,393 priority patent/US20020137186A1/en
Publication of IL107557A publication Critical patent/IL107557A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16541—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16541—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16545—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL10755793A 1993-11-10 1993-11-10 Lymphotropic agents and vectors IL107557A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL10755793A IL107557A (en) 1993-11-10 1993-11-10 Lymphotropic agents and vectors
AU10885/95A AU1088595A (en) 1993-11-10 1994-11-09 Lymphotropic agents and vectors
US08/646,242 US6503752B1 (en) 1993-11-10 1994-11-09 Lymphotropic agents and vectors
PCT/US1994/012715 WO1995013081A1 (en) 1993-11-10 1994-11-09 Lymphotropic agents and vectors
US10/061,393 US20020137186A1 (en) 1993-11-10 2002-02-04 Lymphotropic agents and vectors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10755793A IL107557A (en) 1993-11-10 1993-11-10 Lymphotropic agents and vectors

Publications (2)

Publication Number Publication Date
IL107557A0 IL107557A0 (en) 1994-02-27
IL107557A true IL107557A (en) 2005-06-19

Family

ID=11065437

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10755793A IL107557A (en) 1993-11-10 1993-11-10 Lymphotropic agents and vectors

Country Status (3)

Country Link
AU (1) AU1088595A (en)
IL (1) IL107557A (en)
WO (1) WO1995013081A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008047656A1 (en) 2006-10-12 2010-02-25 株式会社カネカ Method for producing L-amino acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242820A (en) * 1986-06-18 1993-09-07 American Registry Of Pathology Pathogenic mycoplasma
US5230997A (en) * 1990-07-19 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting the presence of human herpesvirus-7 infection
DE4110962A1 (en) * 1991-04-05 1992-10-08 Bayer Ag EQUINE HERPESVIREN (EHV) CONTAINING FOREIGN DNA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN Vaccines

Also Published As

Publication number Publication date
IL107557A0 (en) 1994-02-27
AU1088595A (en) 1995-05-29
WO1995013081A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
GB9300051D0 (en) Therapeutic agents
GB9316901D0 (en) Sunscreen agents
GB9309573D0 (en) Therapeutic agents
GB2281830B (en) I/q-modulator and i/q-demodulator
GB9312806D0 (en) Therapeutic agents
GB9322576D0 (en) Antihaemostatic agents
GB9305644D0 (en) Therapeutic agents
GB9303850D0 (en) Vector
IL107557A (en) Lymphotropic agents and vectors
GB9316646D0 (en) Sunscreen agents
GB9501907D0 (en) Allatostatins and their use
EP0741142A4 (en) Peptide and antithrombotic agent
GB9309380D0 (en) Packaging and other constructions
GB9310099D0 (en) Foaming agents
GB9302721D0 (en) Marcromolecular agents
GB9321595D0 (en) Contrast agents
GB9323678D0 (en) "999"
GB9307831D0 (en) Therapeutic agents
GB9307306D0 (en) Therapeutic agents
GB9307832D0 (en) Therapeutic agents
GB9305619D0 (en) Therapeutic agents
GB9305628D0 (en) Therapeutic agents
GB9307278D0 (en) Therapeutic agents
GB9301277D0 (en) Therapeutic agents
GB9303243D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees